This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Dxgen Corp.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Seon Ah Cheon: Innovator in Diabetes Diagnostics
Introduction
Seon Ah Cheon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of diabetes diagnostics through his innovative research and development.
Latest Patents
Seon Ah Cheon holds a patent for a "Reagent composition for measuring glycated hemoglobin and method for measuring glycated hemoglobin using same." This invention provides a reagent composition designed to diagnose the presence or absence of diabetes. The composition includes a dye-encapsulated silica nanoparticle-boronic acid, which enhances the measurement of glycated hemoglobin. The encapsulation of the dye in silica nanoparticles ensures that the inherent absorption wavelength of the dye remains unaffected by pH levels, resulting in excellent stability even when stored for one month or more. He has 1 patent to his name.
Career Highlights
Seon Ah Cheon is currently associated with Dxgen Corp., where he continues to advance his research in medical diagnostics. His work focuses on improving the accuracy and reliability of diabetes testing methods.
Collaborations
Seon Ah Cheon collaborates with Jin Woo Lee, contributing to the development of innovative solutions in the healthcare sector.
Conclusion
Seon Ah Cheon is a pioneering inventor whose work in diabetes diagnostics is making a significant impact in the medical field. His innovative approaches are paving the way for more effective diagnostic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile